ARTICLE
8 December 2022

The "Unofficial" CN Orange Book User Guide For Pharmaceutical Patents

TM
Toby Mak

Contributor

Dr. Toby Mak is somewhat unique as a registered Chinese patent attorney, as he was trained under the UK patent system, and has passed some of the UK patent attorney’s examination papers. He actively publishes articles on Chinese IP, and speaks on Chinese IP for various organizations around the world.
Toby's Nov 2022 version of "The "Unofficial" CN Orange Book user guide for pharmaceutical patents".
China Intellectual Property

Toby's Nov 2022 version of "The "Unofficial" CN Orange Book user guide for pharmaceutical patents".

This is out at the IPO Journal, and is available at the link below:

https://lnkd.in/g7-RB4Dd

This Nov 2022 version has the following updates:

  1. Inclusion of data in Nov 2022, including the number of entries in the "CN Orange Book", and updates on patent linkage declarations filed.
  2. Discussion of the first drug patent linkage appeal decision issued by the CN Supreme Court in Aug 2022.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More